Laurion Capital Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,128,889
| Closed | -$7.54M | – | 251 |
|
2023
Q3 | $7.54M | Buy |
1,128,889
+127,512
| +13% | +$852K | 0.05% | 72 |
|
2023
Q2 | $8.4M | Buy |
1,001,377
+44,477
| +5% | +$373K | 0.05% | 52 |
|
2023
Q1 | $9.5M | Hold |
956,900
| – | – | 0.06% | 48 |
|
2022
Q4 | $6.66M | Hold |
956,900
| – | – | 0.03% | 71 |
|
2022
Q3 | $5.11M | Sell |
956,900
-14,881
| -2% | -$79.5K | 0.03% | 86 |
|
2022
Q2 | $3.88M | Buy |
+971,781
| New | +$3.88M | 0.06% | 81 |
|
2018
Q4 | – | Sell |
-200,000
| Closed | -$2.76M | – | 679 |
|
2018
Q3 | $2.76M | Buy |
+200,000
| New | +$2.76M | 0.03% | 180 |
|